Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes – A systematic review and meta-analysis
Yilin Yoshida, Preeti G. Joshi, Saba Barri, Jia Wang, Amy Corder, Samantha O’Connell, Vivian Fonseca
Topics & Concepts
MedicineLiraglutideSemaglutideDulaglutideInternal medicineType 2 diabetesConfoundingMeta-analysisDiabetic retinopathyPlaceboRandomized controlled trialAdverse effectDiabetes mellitusOdds ratioGlucagon-like peptide 1 receptorEndocrinologyAgonistAlternative medicineReceptorPathologyDiabetes Treatment and ManagementRetinal Diseases and TreatmentsDiabetes Management and Research